TI
HTGM

Truepoint Inc’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Truepoint Inc’s Portfolio HTGM Stock Details HTGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-56
Closed -$69K – 111
2017
Q1 		$69K Buy
+56
New +$27K 0.01% 94

Other funds holding HTGM

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Truepoint Inc's HTGM Position: Q2 2017 in Review

Truepoint Inc sold out of HTG Molecular Diagnostics, Inc. Common Stock (HTGM) in Q2 2017, closing a stake of 56 shares — an estimated $69K sold.

Truepoint Inc first reported a position in HTGM in Q1 2017 and held it in 1 quarter. The position peaked at $69K in Q1 2017. 18 funds tracked by Wall St. Rank hold HTGM as of Q2 2017.

  • Truepoint Inc reported no remaining HTG Molecular Diagnostics, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Truepoint Inc sold 56 HTG Molecular Diagnostics, Inc. Common Stock shares in Q2 2017, an estimated $69K.
  • Truepoint Inc first reported a position in HTG Molecular Diagnostics, Inc. Common Stock in Q1 2017 and held it in 1 quarter.
  • Truepoint Inc's HTG Molecular Diagnostics, Inc. Common Stock position peaked at $69K in Q1 2017.
  • 18 funds tracked by Wall St. Rank held HTG Molecular Diagnostics, Inc. Common Stock as of Q2 2017.

Based on Truepoint Inc's 13F filing for Q2 2017, filed 4 Aug 2017.